Results 91 to 100 of about 85,967 (221)

Chronic Effects of Subcutaneous Interleukin-2 Therapy on Soluble Interleukin-2 Receptors in Advanced Small Cell Lung Cancer

The International Journal of Biological Markers, 1993
The increase in IL-2 receptor serum levels is one of the most typical changes in immune parameters during IL-2 cancer immunotherapy. To better define the effects of prolonged IL-2 injection on SIL-2R levels, we evaluated 7 advanced small cell lung cancer
S. Viviani, P.M. Salvini, P. Bidoli, E. Camerini, S. Spinazzé, F. Arienti, L. Rivoltini, V. Motta   +7 more
doaj   +1 more source

YKL-40, Soluble IL-2 Receptor, Angiotensin Converting Enzyme and C-Reactive Protein: Comparison of Markers of Sarcoidosis Activity

Biomolecules, 2018
The aims of this study were to describe the clinical, radiological and immunological features of a population of sarcoidosis patients and to analyse chitinase-3-like protein 1 (YKL-40), soluble interleukin-2 receptor (sIL-2R), neopterin concentrations ...
Pelin Uysal, Sinem Durmus, Volkan Sozer, Remise Gelisgen, Ekrem Cengiz Seyhan, Fusun Erdenen, Gonul Simsek, Hafize Uzun   +7 more
doaj   +1 more source

Cytokines and depression in cancer patients and caregivers. [PDF]

, 2017
Objective:A better understanding of the biobehavioral mechanisms underlying depression in cancer is required to translate biomarker findings into clinical interventions.
Boutros, Paul C, Kouzmina, Ekaterina, Li, Madeline, McCusker, Megan, Paige, Christopher J, Rodin, Danielle, Rodin, Gary   +6 more
core   +2 more sources

Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy

BMC Cancer, 2017
Background Renal cell carcinoma (RCC) is a tumor with immunogenic properties. Soluble interleukin-2 receptor (sIL-2R) has a role in T cell activation and may be important for immune regulation in various conditions, including infections, transplantation ...
Akinori Nukui, Akinori Masuda, Hideyuki Abe, Kyoko Arai, Ken-Ichiro Yoshida, Takao Kamai   +5 more
doaj   +1 more source

Understanding the role of P2X7 in affective disorders—are glial cells the major players? [PDF]

, 2015
Pathophysiology associated with several psychiatric disorders has been linked to inflammatory biomarkers. This has generated a theory of major depressive disorders as an inflammatory disease.
Jenkins, Trisha A., Spencer, Sarah J., Stokes, Leanne   +2 more
core   +2 more sources

Correlation of serum tumor necrosis factor-α, interleukin-4 and soluble interleukin-2 receptor levels with radiologic and clinical manifestations in active pulmonary tuberculosis

Mediators of Inflammation, 2003
The precise clinical manifestations of tuberculosis are likely to result from a complex interaction between the host and the pathogen. We took serum samples from a group of patients with a variety of clinical and radiological stages of pulmonary ...
Levent Kart, Hakan Buyukoglan, Ishak O. Tekin, Remzi Altin, Zuhal Senturk, Inci Gulmez, Ramazan Demir, Mustafa Ozesmi   +7 more
doaj   +1 more source

Coagulation, fibrinolysis, and cell activation in patients and shed mediastinal blood during coronary artery bypass grafting with a new heparin-coated surface [PDF]

, 2002
Objectives: Heparin coating of the cardiopulmonary bypass circuit is shown to improve the biocompatibility of the surface. We have studied a new heparin surface, the Corline Heparin Surface, applied to a complete set of an extracorporeal device used ...
Johnell, Matilda, Elgue, Graciela, Larsson, Rolf, Larsson, Anders, Thelin, Stefan, Siegbahn, Agneta   +5 more
core   +1 more source

A combined biomarker and clinical panel for chronic graft versus host disease diagnosis. [PDF]

, 2017
Whilst many chronic graft versus host disease (cGVHD) biomarkers have been previously reported, few have been verified in an independent cGVHD cohort. We aimed to verify the diagnostic accuracy of previously reported markers of cGVHD in a multi-centre ...
Flowers, Mary Ed, Hansen, John A, Hsieh, Sue, Inamoto, Yoshi, Lee, Stephanie J, Martin, Paul J, Pidala, Joseph, Sarwal, Minnie M, Sigdel, Tara K, Wang, Anyou   +9 more
core  

Retracted: Effects of Gemcitabine and Oxaliplatin Combined with Apatinib on Immune Function and Levels of SIL-2R and sicAM-1 in Patients with Gallbladder Cancer. [PDF]

Comput Intell Neurosci, 2023
Intelligence And Neuroscience C.
europepmc   +1 more source

Emapalumab for Maladaptive Interferon‐γ‐Mediated Inflammation in Drug Reaction With Eosinophilia and Systemic Symptoms Complicating First‐Line Antituberculosis Therapy

Pediatric Blood &Cancer, Volume 72, Issue 12, December 2025.
Yahya Almodallal, Daniel Whitehurst, Sing Sing Way, Jane Koo, Ashish R. Kumar   +4 more
wiley   +1 more source